5-Lipoxygenase Contributes to Benzo[a]pyrene-Induced Cytotoxicity and DNA Damage in Human Bronchial Epithelial Cells. (March 2023)

• Record Type: Journal Article
• Authors: Huang, Yun; Wang, Jing; Huang, Shaoling; Zhang, Xinge; Hu, Jianan
• Is Part Of: International journal of toxicology. Volume 42:Number 2(2023)
• Page Start: 172
• Page End: 181
• Publication Date: 2023-03
• Subjects: RNA interference -- 5-lipoxygenase -- benzo[a]pyrene -- cytotoxicity -- DNA damage; Toxicology -- Periodicals; 615.9005
• DOI: 10.1177/10915818221146286
• Languages: English
• ISSNs: 1091-5818

Abstract

Metabolic activation of indirect-acting carcinogens in target organs is a recognized mechanism of carcinogenesis. This study aimed to determine the role of benzo[a]pyrene (BaP) metabolism enzymes lipoxygenase (LOX), cytochrome P4501A1 (CYP1A1), and prostaglandin synthetase (PGS) in the cytotoxicity and DNA damage induced by BaP in the human tracheobronchial epithelial cells (HBECs) using RNA interference strategy and metabolic enzyme inhibitors. Our results showed that in three epithelial cell lines (HBE, HTR-8/SVneo, and HaCat), BaP significantly upregulated 5-LOX protein expression. 15-LOX-2 expression also increased with increasing BaP concentration, but the change was less pronounced than that of 5-LOX. BaP caused significant cytotoxicity, DNA strand breaks, and 8-hydroxy-2'-deoxyguanosine formation in HBE, which was inhibited by 5-LOXshRNA, a specific inhibitor of 5-LOX (AA861), the CYP1A1 inhibitor α-naphthoflavone, and the PGS inhibitor naproxen. The protective effects of 5-LOXshRNA were stronger than AA861, naproxen and α-naphthoflavone. We conclude that BaP may be activated more by 5-LOX than by CYP1A1 and PGS to produce cytotoxicity and DNA damage in HBE.